Literature DB >> 32723002

Review of the Omnipod® 5 Automated Glucose Control System Powered by Horizon™ for the treatment of Type 1 diabetes.

Erin C Cobry1, Cari Berget1, Laurel H Messer1, Gregory P Forlenza1.   

Abstract

Type 1 diabetes (T1D) is a medical condition that requires constant management, including monitoring of blood glucose levels and administration of insulin. Advancements in diabetes technology have offered methods to reduce the burden on people with T1D. Several hybrid closed-loop systems are commercially available or in clinical trials, each with unique features to improve care for patients with T1D. This article reviews the Omnipod® 5 Automated Glucose Control System Powered by Horizon™ and the safety and efficacy data to support its use in the management of T1D.

Entities:  

Keywords:  AP; CGM; HCL; Omnipod® 5 System; T1D; artificial pancreas; automated insulin delivery; insulin pump

Year:  2020        PMID： 32723002     DOI： 10.4155/tde-2020-0055

Source DB:  PubMed          Journal:  Ther Deliv        ISSN： 2041-5990


  5 in total

Review 1.  Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits.

Authors:  Meghan E Pauley; Kalie L Tommerdahl; Janet K Snell-Bergeon; Gregory P Forlenza
Journal:  Curr Cardiol Rep       Date:  2022-10-24       Impact factor: 3.955

2.  Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With Diabetes.

Authors:  Cari Berget; Jennifer L Sherr; Daniel J DeSalvo; Ryan S Kingman; Sheri L Stone; Sue A Brown; Alex Nguyen; Leslie Barrett; Trang T Ly; Gregory P Forlenza
Journal:  Clin Diabetes       Date:  2022-04-15

Review 3.  Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives.

Authors:  Federico Boscari; Angelo Avogaro
Journal:  Rev Endocr Metab Disord       Date:  2021-03-23       Impact factor: 6.514

4.  Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.

Authors:  Dana M Lewis; Sufyan Hussain
Journal:  Diabetes Ther       Date:  2022-08-01       Impact factor: 3.595

5.  Evaluation of real-life clinical outcomes in Australian youth with type 1 diabetes on hybrid closed-loop therapy: A retrospective study.

Authors:  Sathyakala Vijayanand; Paul G Stevenson; Elizabeth Broad; Elizabeth A Davis; Craig E Taplin; Timothy W Jones; Mary B Abraham
Journal:  J Paediatr Child Health       Date:  2022-05-31       Impact factor: 1.929
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.